Hans Guenter Drexler

Hans Guenter Drexler's AcademicInfluence.com Rankings

Biology

#9078

World Rank

#12237

Historical Rank

Genetics

#921

World Rank

#1017

Historical Rank

Molecular Biology

#1208

World Rank

#1234

Historical Rank

Biochemistry

#1357

World Rank

#1478

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Hans Guenter Drexler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hans Guenter Drexler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders (2010) (1114)
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia (2004) (432)
Check your cultures! A list of cross‐contaminated or misidentified cell lines (2010) (422)
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing (2012) (404)
Widespread intraspecies cross‐contamination of human tumor cell lines arising at source (1999) (373)
Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention (2002) (284)
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. (1996) (278)
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party. (2008) (216)
The Pearson product‐moment correlation coefficient is better suited for identification of DNA fingerprint profiles than band matching algorithms (1993) (198)
Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. (1993) (176)
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. (2014) (162)
Match criteria for human cell line authentication: Where do we draw the line? (2013) (161)
Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. (1992) (159)
Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. (1991) (153)
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. (2009) (151)
Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines (2002) (148)
Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. (1998) (140)
Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. (1989) (134)
The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). (2003) (131)
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines (2002) (130)
ECV304 (endothelial) is really T24 (bladder carcinoma): Cell line cross-contamination at source (1999) (127)
Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification (2012) (127)
Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). (2000) (121)
Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. (1995) (121)
Detecting mycoplasma contamination in cell cultures by polymerase chain reaction. (2011) (120)
DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control (2015) (120)
Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. (1993) (120)
Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles. (1986) (117)
Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. (2000) (112)
Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. (1987) (110)
Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines. (1993) (106)
BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance (2011) (104)
Guide to Leukemia-Lymphoma Cell Lines on CD. (2005) (102)
Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. (2000) (102)
Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. (1995) (99)
Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells. (1992) (95)
The Leukemia-Lymphoma Cell Line Factsbook (2000) (95)
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. (2004) (94)
Detection of mycoplasma contaminations. (2013) (93)
Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. (1995) (93)
Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. (1992) (85)
Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines (1997) (85)
Mini ReviewFLT3: Receptor and Ligand (2004) (84)
Mycoplasma contamination in human leukemia cell lines. I. Comparison of various detection methods. (1992) (82)
Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. (1999) (80)
Cell line cross‐contamination initiative: An interactive reference database of STR profiles covering common cancer cell lines (2010) (80)
Detection of Mycoplasma Contamination in Cell Cultures (2014) (80)
Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia (2009) (76)
Expression and function of CD95 (FAS/APO‐1) in leukaemia‐lymphoma tumour lines (1997) (74)
Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. (2007) (74)
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. (2016) (73)
Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia (2011) (69)
Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1. (2007) (68)
Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells. (1989) (68)
Expression of HOX Genes in Acute Leukemia Cell Lines with and without MLL Translocations (2004) (67)
Activation of HOX11L2 by juxtaposition with 3′‐BCL11B in an acute lymphoblastic leukemia cell line (HPB‐ALL) with t(5;14)(q35;q32.2) (2003) (66)
Mix-ups and mycoplasma: the enemies within. (2002) (66)
Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma (2008) (64)
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines (2008) (62)
Short tandem repeat DNA typing provides an international reference standard for authentication of human cell lines. (2005) (62)
Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. (1994) (61)
FLT3: receptor and ligand. (2004) (61)
Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. (2003) (60)
Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells. (1999) (60)
The LL-100 panel: 100 cell lines for blood cancer studies (2019) (60)
History and classification of human leukemia-lymphoma cell lines. (1998) (59)
Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. (2010) (56)
Morphological and isoenzymatic differentiation of B-chronic lymphocytic leukaemia cells induced by phorbolester. (1986) (56)
Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms. (2015) (56)
Cytogenetic harvesting of commonly used tumor cell lines (2007) (54)
Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. (1996) (53)
Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells. (1996) (53)
STR DNA typing of human cell lines: detection of intra- and interspecies cross-contamination. (2013) (52)
Many are called MDS cell lines: one is chosen. (2009) (51)
Interleukins and colony stimulating factors in human myeloid leukemia cell lines. (1995) (51)
Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells (1997) (51)
SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines (2009) (51)
Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia. (1993) (51)
Expression of the FLT3 gene in human leukemia-lymphoma cell lines. (1994) (49)
Isoenzyme studies in human leukemia-lymphoma cell lines--1. Carboxylic esterase. (1985) (49)
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations (2012) (48)
Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. (2004) (47)
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms (2011) (46)
Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. (1996) (46)
SOCS2: inhibitor of JAK2V617F-mediated signal transduction (2008) (45)
Human leukemia and lymphoma cell lines as models and resources. (2008) (43)
Analysis of TEL proteins in human leukemias (1998) (43)
Treatment of Mycoplasma Contamination in Cell Cultures with Plasmocin (2012) (43)
Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril). (1994) (42)
Bladder carcinoma cell line ECV304 is not a model system for endothelial cells (2002) (42)
Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: suggestion for classification by immunophenotype and T-cell receptor studies. (1999) (40)
Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. (1996) (40)
Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis (2016) (39)
Hodgkin's disease: a cytokine-producing tumor--a review. (1994) (39)
Modulation of gene expression in the acute promyelocytic leukemia cell line NB4. (1993) (39)
Differential expression of the ufo/axl oncogene in human leukemia-lymphoma cell lines. (1996) (39)
Deregulated FOX genes in Hodgkin lymphoma (2014) (39)
t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5 (2012) (39)
Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. (1995) (39)
Enzyme markers in acute leukemias: advances during the last decade. (1984) (39)
Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines. (1998) (38)
Inhibition of PI3K/mTOR Overcomes Nilotinib Resistance in BCR-ABL1 Positive Leukemia Cells through Translational Down-Regulation of MDM2 (2013) (38)
Comparative antibiotic eradication of mycoplasma infections from continuous cell lines (2002) (38)
Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes (2012) (37)
Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. (1993) (37)
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia (2017) (37)
Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma. (2012) (37)
Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia (2009) (36)
Genotypes and immunophenotypes of Hodgkin's disease-derived cell lines. (1988) (36)
8 – Hematopoietic Cell Lines (1994) (36)
Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines. (1993) (36)
Hodgkin's disease derived cell lines: a review. (1992) (36)
Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells. (1992) (36)
Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing (2013) (36)
False and mycoplasma‐contaminated leukemia–lymphoma cell lines: time for a reappraisal (2017) (35)
Leukemia cell lines: in vitro models for the study of chronic myeloid leukemia. (1994) (35)
Mycoplasma Contamination Of Cell Cultures (2003) (35)
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in Human and Other Primate Cell Lines (2010) (35)
First searchable database for DNA profiles of human cell lines: sequential use of fingerprint techniques for authentication. (1999) (35)
Biology of Monocyte-Specific Esterase (2000) (34)
Biology of Tartrate-Resistant Acid Phosphatase (2000) (34)
Immunocytochemical Analysis of Cell Lines Derived from Solid Tumors (2001) (34)
Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinase. (2003) (34)
Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma. (2002) (34)
c-kit Expression in Human Megakaryoblastic Leukemia Cell Lines (1994) (34)
Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma (2010) (33)
Human Cell Culture (2002) (33)
Expression of the growth arrest-specific gene 6 (GAS6) in leukemia and lymphoma cell lines. (1999) (33)
Hodgkin's disease-derived cell lines--conflicting clues for the origin of Hodgkin's disease? (1987) (33)
Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting (1997) (33)
Human Cell Culture (2002) (33)
NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia (2017) (32)
Multicolor-FISH analysis of a natural killer cell line (NK-92). (2002) (32)
The phylogeny of proteinase 3/myeloblastin, the autoantigen in Wegener's granulomatosis, and myeloperoxidase as shown by immunohistochemical studies on human leukemic cell lines. (1994) (32)
IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. (2018) (32)
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines. (1996) (31)
Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia. (2004) (31)
Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines. (2002) (31)
Detection of mycoplasma contaminations. (2005) (30)
Detecting Mycoplasma contamination in cell cultures by polymerase chain reaction. (2004) (30)
NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells (2009) (30)
Online verification of human cell line identity by STR DNA typing. (2011) (30)
Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia (2011) (30)
Characterization and expression of tartrate-resistant acid phosphatase (TRAP) in hematopoietic cells. (1994) (29)
The PCBP1 gene encoding poly(rc) binding protein i is recurrently mutated in Burkitt lymphoma (2015) (29)
Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia (2011) (29)
Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines (2009) (29)
Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2. (1986) (29)
Mycoplasma contamination in human leukemia cell lines. II. Elimination with various antibiotics. (1992) (29)
Secretion of functional hematopoietic growth factors by human carcinoma cell lines (1998) (28)
e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia (2005) (28)
Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. (2010) (28)
Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset (2015) (28)
The use of monoclonal antibodies for the identification and classification of acute myeloid leukemias. (1986) (28)
t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2 (2011) (28)
History of leukemia-lymphoma cell lines (2010) (27)
DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4) (2012) (27)
Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML‐M4 cell line (GDM‐1) (2005) (27)
Analysis of signal transduction in B chronic lymphocytic leukemia cells. (1988) (26)
U-2932: two clones in one cell line, a tool for the study of clonal evolution (2013) (26)
In vitro culture studies of childhood myelodysplastic syndrome: establishment of the cell line MUTZ-1. (1997) (26)
Detection of mycoplasma contaminations in cell cultures by PCR analysis. (1999) (26)
Efficient DNA fingerprinting method for the identification of cross-culture contamination of cell lines. (1999) (26)
Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes. (2000) (26)
Cytogenetic analysis of cancer cell lines. (2011) (26)
Synergistic action of calcium ionophore A23187 and phorbol ester TPA on B-chronic lymphocytic leukemia cells. (1987) (26)
Transfection and gene expression in normal and malignant primary B lymphocytes. (1990) (25)
FLT3 ligand inhibits apoptosis and promotes survival of myeloid leukemia cell lines. (1999) (25)
Isoenzyme studies in human leukemia — III. β-hexosaminidase (E.C. 3.2.1.30) (1983) (25)
Leukemia-lymphoma cell lines as model systems for hematopoietic research (2003) (24)
Expression of BEX1 in acute myeloid leukemia with MLL rearrangements (2005) (24)
Immunophenotypic and enzymatic studies do not support the concept of mixed monocytic‐granulocytic differentiation in acute promyelocytic leukaemia (M3): a study of 44 cases (1989) (24)
Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma (2015) (23)
Ectopic Expression of Homeobox Gene NKX2-1 in Diffuse Large B-Cell Lymphoma Is Mediated by Aberrant Chromatin Modifications (2013) (23)
Interleukin 2 enhances cytotoxic cell function in vitro after T‐cell depleted marrow transplantation (1987) (23)
Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines. (1996) (22)
MUTZ‐3, a monocytic model cell line for interleukin‐4 and lipopolysaccharide studies (1996) (22)
Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore. (1989) (22)
Stable expression of MutLγ in human cells reveals no specific response to mismatched DNA, but distinct recruitment to damage sites (2013) (22)
Isoenzyme studies in human leukemia-lymphoma cells lines--II. Acid phosphatase. (1985) (22)
Isoenzyme studies in human leukemia-lymphoma cell lines--III. beta-Hexosaminidase (E.C. 3.2.1.30). (1985) (22)
Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas (2016) (22)
Incidence of TdT positivity in cases of leukemia and lymphoma. (1986) (22)
Isoenzyme studies in human leukemia-lymphoma cell lines--IV. Lactate dehydrogenase. (1985) (21)
Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines (2015) (21)
Persistent use of misidentified cell lines and its prevention (2002) (21)
Mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny (2009) (21)
Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease (1999) (21)
CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation (2010) (21)
Isoenzyme analysis as a rapid method for the examination of the species identity of cell cultures (1995) (21)
Isoenzyme studies in human leukemia -- II. Carboxylic esterase (E.C. 3.1.1.1.). (1983) (21)
NKL homeobox gene activities in B-cell development and lymphomas (2018) (20)
KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia (2018) (20)
MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death (2016) (20)
Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma (2015) (20)
Hodgkin lymphoma cell lines: to separate the wheat from the chaff (2018) (20)
Treatment of mycoplasma contamination in a large panel of cell cultures (1994) (19)
Oncogenic deregulation of NKL homeobox gene MSX1 in mantle cell lymphoma (2014) (19)
Growth-inhibitory effects of transforming growth factor-β1 on myeloid leukemia cell lines (1998) (19)
Mono Mac 6: a mature monoblastic leukemia cell line with t(9;11)(p21;q23) (1993) (19)
Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines. (1995) (19)
Expression of the monocyte-specific esterase gene in leukemia-lymphoma cell lines. (1993) (18)
Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma (2010) (18)
Cytogenetic characterization of tumor cell lines. (2004) (18)
Multiparameter approach in the identification of cross-contaminated leukemia cell lines. (1993) (18)
Prevalence and Characterization of Murine Leukemia Virus Contamination in Human Cell Lines (2015) (18)
A simple method using β-globin polymerase chain reaction for the species identification of animal cell lines—A progress report (2003) (18)
Authentication of cancer cell lines by DNA fingerprinting. (2004) (18)
Authentication of scientific human cell lines: easy-to-use DNA fingerprinting. (2005) (18)
Eradication of mycoplasma contaminations. (2005) (18)
BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia. (2004) (18)
Elimination of mycoplasmas from infected cell lines using antibiotics. (2011) (18)
Identification and verification of rodent cell lines by polymerase chain reaction (2007) (17)
T-leukemia cell lines CCRF-CEM, HPB-ALL, JM and MOLT-4: Changes in isoenzyme profiles during induction of differentiation (1987) (17)
Tumor necrosis factor-α–induced proliferation requires synthesis of granulocyte-macrophage colony-stimulating factor (2000) (17)
Mycoplasma detection by PCR analysis (1993) (17)
Monocyte esterase? A factor involved in the pathogenesis of lymphoproliferative neoplasia. (1987) (17)
Eradication of Mycoplasma Contaminations from Cell Cultures (2014) (17)
Treatment of mycoplasma-contaminated continuous cell lines with mycoplasma removal agent (MRA). (1992) (17)
Occurrence of particular isoenzymes in fresh and cultured leukemia‐lymphoma cells. I. Tartrate‐resistant acid phosphatase isoenzyme (1986) (17)
Expression of proto-oncogene c-jun during differentiation of B-chronic lymphocytic leukemia. (1990) (17)
Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells (2020) (17)
A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report (2018) (17)
Malignant hematopoietic cell lines: in vitro models for the study of mast cell leukemia. (2003) (16)
Identification of a tumor suppressor network in T-cell leukemia (2017) (16)
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia. (2012) (16)
Transcriptional Activation of Prostate Specific Homeobox Gene NKX3-1 in Subsets of T-Cell Lymphoblastic Leukemia (T-ALL) (2012) (16)
Biochemical aspects of acute leukaemia. (1986) (16)
DNA profiling and cytogenetic analysis of cell line WSU-CLL reveal cross-contamination with cell line REH (pre B-ALL) (2002) (16)
Human bone marrow stroma‐dependent cell line MOLP‐5 derived from a patient in leukaemic phase of multiple myeloma (2000) (16)
Cross-contamination: HS-Sultan is not a myeloma but a Burkitt lymphoma cell line. (2001) (16)
Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing δ/λ type immunoglobulin (2004) (16)
Incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. (1993) (15)
Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma (2015) (15)
The necessity of identity assessment of animal intestinal cell lines: A case report (2012) (15)
Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma (2016) (15)
A case of TdT-positive B-cell acute lymphoblastic leukemia. (1986) (15)
Chromothripsis in Hodgkin lymphoma (2013) (15)
Characterization of Hodgkin's disease derived cell line HDLM-2. (1989) (15)
NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma (2018) (14)
Mantle cell lymphoma-derived cell lines: unique research tools. (2006) (14)
Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia (2016) (14)
Biochemical enzyme analysis in acute leukaemia. (1985) (14)
Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin. (2004) (13)
Cell banks detect false cell lines: journals must act too. (2001) (13)
BCL6 – regulated by AhR/ARNT and wild-type MEF2B – drives expression of germinal center markers MYBL1 and LMO2 (2015) (13)
Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL (2019) (13)
"Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping. (1985) (13)
Screening human cell lines for viral infections applying RNA-Seq data analysis (2019) (13)
Polycomb Repressor Complex 2 Regulates HOXA9 and HOXA10, Activating ID2 in NK/T-Cell Lines. (2009) (12)
DIFFERENTIAL RECOVERY OF PHENOTYPICALLY AND FUNCTIONALLY DISTINCT CIRCULATING ANTIGEN‐PRESENTING CELLS AFTER ALLOGENEIC MARROW TRANSPLANTATION (1988) (12)
Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies. (1988) (12)
Subsets of normal mononuclear cells in the peripheral blood defined by monoclonal antibodies. (1985) (12)
Elimination of Mycoplasma from infected cell lines using antibiotics. (2004) (12)
Cytostatic Effects of Dolastatin 10 and Dolastatin 15 on Human Leukemia Cell Lines (1992) (12)
Chromatid aberration dose responses and dispersal in human G2 lymphocytes treated with bleomycin: comparison with equivalent X-irradiation reveals formation of a novel class of heavily damaged cells. (1994) (12)
Persistent use of false myeloma cell lines (2003) (12)
Malignant hematopoietic cell lines: in vitro models for the study of Waldenström's macroglobulinemia. (2008) (12)
Public repositories: users reluctant to give materials (2006) (12)
Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma (2018) (11)
Changes in isoenzyme profiles during induction of differentiation in human myelomonocytic leukemia cell lines. (1986) (11)
Occurrence of particular isoenzymes in fresh and cultured leukemia‐lymphoma cells: II. Hexosaminidase I isoenzyme (1986) (11)
Prevention of mycoplasma contamination in leukemia-lymphoma cell lines. (2001) (11)
One falsehood leads easily to another (2008) (11)
The use of enzyme marker analysis for subclassification of acute lymphocytic leukemia in childhood. (1982) (11)
Elimination of Mycoplasma Contamination in Cell Cultures (1996) (11)
NFkB is activated by multiple mechanisms in hairy cell leukemia (2015) (11)
NKL homeobox gene activities in normal and malignant myeloid cells (2019) (11)
Malignant hematopoietic cell lines: in vitro models for the study of primary mediastinal B-cell lymphomas. (2015) (11)
Enhanced whole exome sequencing by higher DNA insert lengths (2016) (11)
NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia. (2017) (11)
Differential expression of MHC class II antigens in chronic B-cell disorders. (1988) (11)
Deregulated expression of NKL homeobox genes in T-cell lymphomas (2019) (10)
The Human Tartrate-Resistant Acid Phosphatase (TRAP): Involvement of the Hemin Responsive Elements (HRE) in Transcriptional Regulation (2000) (10)
Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1. (1993) (10)
Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma (2021) (10)
Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens. (2002) (10)
CD5-positive B cells after T cell depleted bone marrow transplantation. (1987) (10)
Neoplastic MiR‐17∼92 deregulation at a dna fragility motif (SIDD) (2012) (10)
Cytogenetic analysis of cell lines. (2005) (10)
Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia (2017) (10)
Monocytoid leukemia cell line CTV-1: morphological, immunological and isoenzymatic characteristics. (1986) (10)
Monocyte‐specific esterase isoenzyme demonstrated by isoelectric focusing (1990) (9)
Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line (1996) (9)
Cell line cross-contamination: WSU-CLL is a known derivative of REH and is unsuitable as a model for chronic lymphocytic leukaemia. (2014) (9)
Establishment and culture of leukemia-lymphoma cell lines. (2011) (9)
Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype. (2003) (9)
Expression of a monocyte-specific esterase isoenzyme in cases of acute myeloid leukemias. (1985) (9)
In vitro beta 2-microglobulin (beta 2m) secretion by normal and leukaemic B-cells: effects of recombinant cytokines and evidence for a differential response to the combined stimulus of phorbol ester and calcium ionophore. (1990) (9)
High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia (2015) (9)
Would the real Waldenström cell line please stand up? (2013) (9)
Interferon‐gamma induced proliferation of human myeloid leukaemia cell lines (1997) (9)
Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemias. (1986) (9)
Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance. (1986) (8)
Differential expression of TRAP Isoenzyme in B-CLL Cells Treated with Different Inducers. (1990) (8)
RBFOX2 and alternative splicing in B-cell lymphoma (2018) (8)
NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia (2017) (8)
Routine immunophenotyping of acute leukaemias (1988) (8)
Incidence, Biologic Features and Treatment Outcome of Myeloid-Antigen-Positive Acute Lymphoblastic Leukemia (My + ALL) (1994) (8)
Transcription factor expression in cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma (2008) (8)
Granulocyte-macrophage colony-stimulating factor: inhibitor of tumor necrosis factor-induced apoptosis. (2003) (8)
The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL) (2020) (8)
The LL-100 Cell Lines Panel: Tool for Molecular Leukemia–Lymphoma Research (2020) (8)
Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing (2016) (8)
Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion (2015) (7)
Establishment of novel B-cell precursor leukemia sister cell lines NALM-36 and NALM-37: shift of immunoglobulin phenotype to double light chain positive B-cell. (2002) (7)
Down‐regulation of CD5 mRNA in B‐chronic lymphocytic leukemia cells by differentiation‐inducing agents (1990) (7)
Eradication of mycoplasma contaminations. (2013) (7)
Classical and molecular cytogenetic analysis. (2013) (7)
Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia (2020) (7)
Diagnostic value of immunological leukemia phenotyping. (1986) (7)
Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells (2017) (7)
Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma (2016) (7)
Early contamination of the Dami cell line by HEL. (1997) (7)
Beta-hexosaminidase isoenzyme I: an early marker of hematopoietic malignancy. (1985) (6)
Chromosomal breakage correlates with delayed lethality in normal and ataxia telangiectasia cell lines treated with bleomycin. (1996) (6)
Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation (2016) (6)
Where have all the cell lines gone? (2013) (6)
Deregulated NKL Homeobox Genes in B-Cell Lymphoma (2019) (6)
Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant. (1987) (6)
New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17). (2004) (6)
Stable and reproducible engraftment of primary adult and pediatric acute myeloid leukemia in NSG mice (2011) (6)
Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia. (1999) (6)
Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset (2018) (6)
Esterase Isoenzyme Profiles in Acute and Chronic Leukemias. (1991) (6)
SET-NUP 214 fusion in acute myeloid leukemia-and T-cell acute lymphoblastic leukemia-derived cell lines (2015) (6)
Malignant hematopoietic cell lines: in vitro models for the study of plasmacytoid dendritic cell leukemia. (2009) (5)
Transcription factor expression in B-cell precursor-leukemia cell lines: preferential expression of T-bet. (2005) (5)
Lymphocytic leukemia and lymphomas. (1990) (5)
Beware imposters: MA‐1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B‐cell lymphoma cell line (2013) (5)
Leukaemia cell lines are robust in vitro models (2008) (5)
Expression of tie receptor tyrosine kinase in human leukemia cell lines. (1997) (5)
Genomic deregulation of PRMT5 supports growth and stress tolerance in chronic lymphocytic leukemia (2020) (5)
Growth-inhibitory effects of transforming growth factor-beta 1 on myeloid leukemia cell lines. (1998) (5)
Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas (2013) (5)
A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique t(6;20)(q15;q11.2) rearrangement. (2006) (5)
In vitro induction of myeloid surface markers in a rare case of acute leukemia (1987) (5)
Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma (2022) (5)
Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma (2018) (5)
Monocytic Cell Lines (2002) (5)
Molecular breakpoint analysis of chromosome translocations in cancer cell lines by Long Distance Inverse-PCR. (2011) (5)
NKL Homeobox Gene VENTX Is Part of a Regulatory Network in Human Conventional Dendritic Cells (2021) (4)
Induction of differentiation in the human leukemia cell line SPI‐802: Morphological, immunological, and isoenzymatic changes (1986) (4)
Isolation and culture of leukemia cell lines. (2004) (4)
Fusion of NUP214 to ABL1 on amplified extrachromosomal elements in T-ALL. (2004) (4)
Cytogenetic Harvesting of Cancer Cells and Cell Lines. (2017) (4)
Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line. (1996) (4)
Pre-B and non-T/non-B leukemia cell lines BV-173, KM-3, NALM-6, and REH: changes in isoenzyme profiles during induction of differentiation. (1986) (4)
Establishment of the Two Cytokine-Dependent Acute Myeloid Leukemia-Derived Cell Lines MUTZ-8 and MUTZ-11 (2003) (4)
Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases. (1987) (4)
Proliferative Hairy Cell Leukaemia (HCL-v) Resistant to Alpha-Interferon: Clinical, Diagnostic and In-Vitro Cellular Characteristics. (1990) (4)
Monocyte-associated acid phosphatase isoenzyme profiles as determined in acute myeloid leukaemia cells. (2009) (4)
BCR–ABL1 expression in multiple myeloma cells: A case of mistaken identity? (2013) (4)
Modulators of histone demethylase JMJD1C selectively target leukemic stem cells (2020) (4)
Human Leukemia-lymphoma Cell Lines: Historical Perspective, State of the Art and Future Prospects (2002) (4)
CD30-Positive Anaplastic Large Cell Lymphoma Cell Lines (2002) (4)
There is a Scientific Need for the Right Leukemia-Lymphoma Cell Lines (2019) (4)
Study on Human T Leukemia-Lymphoma Cell Lines by the Second International Workshop Monoclonal Antibodies of the T Cell Protocol (1986) (4)
Cell line models of leukemia (2005) (3)
Expression of tie receptor tyrosine kinase in human leukemia cell lines (1997) (3)
Spliceosomal Targeting in Acute Myeloid Leukemia Cells with ETV6-NTRK3 Fusion. (2009) (3)
Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines (2004) (3)
Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma. (1996) (3)
Isoenzyme studies in human leukemia -- III. beta-Hexosaminidase (E.C. 3.2.1.30). (1983) (3)
Localization of MLH3 at the Centrosomes (2014) (3)
Proposal for the designation of the natural killer antigens-positive γδ T-cell subset as γδ NKT-cells: nomenclature based on immunoprofile (2021) (3)
Esterase isoenzyme profiles of 255 leukemia-lymphoma cell lines from all hematopoietic cell lineages. (1996) (3)
Significance of the Multiple Marker Analysis of Leukemia Cells (1987) (3)
Correction: Ectopic Expression of Homeobox Gene NKX2-1 in Diffuse Large B-Cell Lymphoma Is Mediated by Aberrant Chromatin Modifications (2013) (3)
The nature of the hodgkin cell (1988) (3)
Cells, lines and DNA fingerprinting (1992) (2)
5 – Establishment and Culture of Cell Lines (2001) (2)
The nature of the Hodgkin cell. Report of the First International Symposium on Hodgkin's Lymphoma, Köln, Federal Republic of Germany, October 2-3, 1987. (1988) (2)
The 1.35-kb and 7.5-kb Duffy mRNA Isoforms Are Differently Regulated in Various Regions of Brain, Differ by the Length of Their 5* Untranslated Sequence, but Encode the Same Polypeptide (1997) (2)
Enhanced proliferative activity of PIXY-321, the granulocyte-macrophage colony-stimulating factor and interleukin-3 fusion protein. (1998) (2)
Phenotyping of malignant hematopoietic cells. Analysis of 1200 cases of leukemia-lymphoma. (1986) (2)
Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines. (1996) (2)
Primary Mediastinal Large B-Cell Lymphoma Exhibits Autonomous BCR Signaling and Responds to the Second Generation BTK Inhibitor Acalabrutinib (2016) (2)
DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4) (2012) (2)
STAG2 (Stromal Antigen 2) (2014) (2)
Changes in isoenzyme patterns expressed by the erythroleukemia cell lines K-562 and HEL after induction of differentiation. (1985) (2)
Authentication and Characterization (2002) (2)
Differential effects of staurosporine and its analogues on chemokine release by promyelocytic leukemia cell line NB-4. (2003) (2)
Isoenzyme studies in human leukemia-lymphoma cell lines--V. Induction of differentiation by T-cell derived differentiation-inducing activity. (1987) (2)
A Novel ALL-L3 Cell Line, BALM-25, Expressing Both Immunoglobulin Light Chains (2004) (2)
Conservation of unreposited cell lines (2007) (2)
A Novel L3-Acute Lymphoblastic Leukemia Cell Line (BALM-27) Carrying Cytoplasmic Immunoglobulin δ Chain but Lacking Expression of Cell Surface Immunoglobulin Chains (2002) (1)
High concordance between marker profiles of 22 human leukemia-lymphoma cell lines tested with the same monoclonal antibodies before and during the second international workshop on human differentiation antigens (2004) (1)
CRLF2 and JAK2 Mutations: Occurrence and Function In Pre-B ALL Cell Lines (2010) (1)
Retrovirus tests of human leukemia/lymphoma cell lines at DSM. (1993) (1)
Interleukins Human and Colony Stimulating Factors in Mveloid Leukemia Cell Lines (1995) (1)
Erythroid - Megakaryocytic Cell Lines (2002) (1)
A HISTOGENETIC MODEL FOR HODGKIN'S DISEASE (HD) DEVELOPMENT IN HIV-POSITIVE (HIV+) AND HIV-NEGATIVE (HIV−) INDIVIDUALS (1999) (1)
Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes. (2005) (1)
Leukemic cell differentiation in childhood leukemias. Analysis by enzyme markers (1984) (1)
Co-Activation of HOXB7 and BCL2/MYC Via Biallelic IGH Rearrangements in a B-Cell Lymphoma Cell Line. (2004) (1)
Peripheral T-cell lymphoma cell line T8ML-1 highlights conspicuous targeting of PVRL2 by t(14;19)(q11.2;q13.3) (2017) (1)
EXPRESSION OF HISTIOCYTE‐ASSOCIATED ANTIGENS ON HODGKIN AND REED‐STERNBERG CELLS: To the Editor: (1988) (1)
Routine immunophenotyping of acute leukemias (Reply) (2005) (1)
假白血病淋巴瘤细胞系 (2009) (1)
Acid Phosphatase Isoenzyme Profiles in Acute and Chronic Leukemias. (1991) (1)
Abstract LB-012: Autonomous, antigen-independent B-cell receptor signalling as a novel pathogenetic mechanism in non-GCB DLBCL (2016) (1)
7 – Mycoplasma Detection and Elimination (2001) (1)
Transcriptional Regulation of Oncogenic MEF2C In T-Cell Acute Lymphoblastic Leukemia (T-ALL). (2010) (1)
SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy? (2018) (1)
Researchrepressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines (2010) (1)
A Simple Method using β-globin PCR for the Species Identification of Animal Cell Lines - A Progress Report (2003) (1)
Different survival of continuous cell lines transported in live or frozen form (1991) (1)
Title Methylation of miR-34 a , miR-34 b / c , miR-1241 and miR-203 in Ph-negative myeloproliferative neoplasms (2012) (1)
Uncorrected Proof Copy (2003) (1)
A Small Molecular Agonist of Histone Demethylase KDM3B Selectively Represses MLL-Rearranged Acute Leukemia (2018) (1)
Significance of enzyme markers as a part of multiple marker analysis in leukemia research. (1985) (1)
Establishment and characterization of new B-cell precursor leukemia cell line NALM-35 (2002) (1)
Normal and Aberrant NKL-Code in B-Cell Development and Lymphoma (2018) (1)
Activation of Paired-Homeobox Gene PITX1 by Del(5)(q31) In T-Cell Acute Lymphoblastic Leukemia (T-ALL) (2010) (1)
DNMT3A R882H mutation in acute myeloid leukemia cell line SET-2. (2019) (1)
Phenotyping of malignant hematopoietic cells (1986) (1)
Genomic and Expression Profiling of Hairy Cell Leukemia Revealed Multiple Mechanisms of NFkB Activation (2014) (1)
Functional Characterization of the BCL11B Breakpoint Region Reveals Multiple Enhancers at Dnase-I Hypersensitive Sites Some of Which Control NK-Family Homeobox Genes in T-ALL Cells with t(5;14)(q35;q32). (2005) (0)
Aberrant Chromatin Modifications Mediate Ectopic Expression of Homeobox Gene NKX2-1 in B-Cell Lymphoma (2012) (0)
Analysis of Epstein-Barr Virus Infections in Lymphoma Cell Lines. (2005) (0)
NKL Homeobox Gene MSX1 Reactivates An Oncogenic Network In Lymphoid and Myeloid Malignancies (2013) (0)
-negative high-grade B-cell lymphomas resembling Burkitt lymphoma MYC A recurrent 11q aberration pattern characterizes a subset of (2014) (0)
line Cross-contamination: HS-Sultan is not a myeloma but a Burkitt lymphoma cell (2011) (0)
Detection of Mycoplasma Contaminations 13 13 (2018) (0)
A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report (2017) (0)
CD24High / FLJ/P1Low Expression Correlates with Bad Prognosis and Shorter Survival in Adult ALL. (2005) (0)
Monocyte Specific Carboxylesterase (2002) (0)
Expression of Homeobox Gene HLXB9 Mediated by Constitutive Active Signal Transduction Pathways Activates IL-6 in Hodgkin’s Disease Cell Lines. (2004) (0)
Tartrate‐Resistant Acid Phosphatase (2002) (0)
and calcium ionophore lymphocytic leukemia cells during differentiation induced by phorbol ester Rapid expression of protooncogenes c-fos and c-myc in B-chronic (2013) (0)
Myelocytic Cell Lines (2002) (0)
Inhibition Of PI3K/mTOR Overcomes Nilotinib Resistance In BCR-ABL1 Positive Leukemia Cells (2013) (0)
Expression analysis of homeobox genes in leukemia/lymphoma cell lines. (2011) (0)
BCL6 Overexpression – Regulated By AhR/ARNT and Wild-Type MEF2B – Drives Expression of Germinal Center Markers MYBL1 and LMO2 (2014) (0)
Enhanced whole exome sequencing by higher DNA insert lengths (2016) (0)
Novel B-cell acute lymphoblastic leukemia sister cell lines BALM 19–23 and BALM-26 with interclonal proliferative and phenotypic heterogeneity from a patient with hypercalcemia (2002) (0)
Review article Biochemical enzymeanalysis inacute leukaemia (1985) (0)
positive chronic eosinophilic leukemia - The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA (2013) (0)
Commentary: what is an 'NK-precursor cell line'? (2002) (0)
Amplification at 7q22 Targets CDK6 in T-Cell Lymphoma. (2007) (0)
FOXR1 Activation in B-Cell Lymphoma (2015) (0)
Localization of MLH 3 at the Centrosomes (2014) (0)
Expression of FLT3 and FLT3 Ligand in Human Leukemia-Lymphoma Cell Lines (1997) (0)
NK-Like Homeodomain Proteins Regulate NOTCH3-Signaling in T-Cells. (2008) (0)
Does cryopreservation with Me2SO alter the epigenome and transcriptome of cryosensitive cancer cell lines (2015) (0)
Biochemical abnormalities in acute leukaemia (1986) (0)
Detection of Viruses in Human Cell Lines Applying Next Generation Sequencing (2016) (0)
Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma (2018) (0)
ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma (2016) (0)
Inhibition of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-ALL after Blocking Remote 3′-BCL11B Enhancer Sequences with Matching DNA Oligos Reveals Coregulation by PU.1 and HMGA1. (2006) (0)
Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma (2022) (0)
Induction of Apoptosis In Imatinib-Resistant BCR-ABL1-Positive Leukemia Cell Lines by Bortezomib (2010) (0)
JAK2 V617F Tyrosine Kinase Mutation in Leukemia Cell Lines. (2005) (0)
MDR1 expression in human leukemia-lymphoma cell lines. (1993) (0)
EZH2-activating mutation: no reliable indicator for efficacy of methyltransferase inhibitors (2020) (0)
Chapter 12 CD30-Positive Anaplastic Large Cell Lymphoma Cell Lines (0)
Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia (2021) (0)
B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens (2022) (0)
INACTIVATING MUTATIONS OF THE HISTONE METHYLTRANSFERASE EZH2 ARE ASSOCIATED WITH CHROMOSOME 7 ABNORMALITIES IN MYELOID DISORDERS (2010) (0)
Widespread BCL6 Rearrangement with Novel Non-Fusogenic Partner Loci Including Common Fragile Sites in B-Cell Non-Hodgkin Lymphoma Cell Lines. (2005) (0)
Hypomethylation of Tumor Suppressor Genes in Acute Myeloid Leukemia: Characteristic of Cell Lines with MLL Abnormalities?. (2009) (0)
Micro-RNA Gene Deregulation by Chromosome Translocations with Fragile Genomic Regions in B-Cell Lymphoma Cells (2008) (0)
RBFOX2 and alternative splicing in B-cell lymphoma (2018) (0)
Editor's/Publisher's Disclaimer (1998) (0)
2.4 Cell Line Monitoring: Molecular Cytogenetic Characterization (2014) (0)
Subject Index Vol. 95, 1996 (1996) (0)
Reed-Sternberg Cells Interleukin 9 Is Expressed by Primary and Cultured Hodgkin Updated (2006) (0)
P065 Coamplification at 8q24 and 11q23 in AML/MDS cell lines (2007) (0)
BEX1, a Marker for Acute Myeloid Leukemia Cell Lines with MLL Rearrangements. (2004) (0)
Comprehensive Analysis of Homeobox Genes in Hodgkin Lymphoma Cell Lines Identified Dysregulated Expression of HOXB9 Mediated by Constitutive Active ERK5 Signalling Pathway and BMI1. (2006) (0)
Hypermethylation of CD44 Is Characteristic of Specific Lymphoma Subtypes. (2009) (0)
2 – History and Classification of Hematopoietic Cell Lines (2001) (0)
6 – Authentication of Cell Lines (2001) (0)
ORIGINAL ARTICLE Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma (2008) (0)
Standard for Authentication of Human Cell Lines (2012) (0)
8 – Availability of Cell Lines and Cell Line Banks (2001) (0)
Characterization of Secondary Alterations in Mantle Cell Lymphomas Using Matrix-/Array CGH. (2004) (0)
Characterization of T-Cell Lymphoma Cell Lines with a Novel t(9;14)(q34;q11.2) Rearrangement: Does gamma-Secretase Inhibitor Sensitivity Depend on Intragenic NOTCH1 Breakpoint?. (2006) (0)
Oncogenic NK-Like Homeodomain Proteins Inhibit Etoposide-Induced Apoptosis in T-ALL Cell Lines by Activation of the Polycistronic miR-17-92 Transcript. (2007) (0)
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor (2023) (0)
Small Molecular Modulators of Histone Demethylases Selectively Inhibits Growth of Hematopoietic Malignancies (2018) (0)
homeobox gene NKX 2-2 is aberrantly expressed in Hodgkin lymphoma (2018) (0)
Contents, Vol. 95, 1996 (1996) (0)
Comprehensive Analysis of Homeobox Gene Expression in Hodgkin Lymphoma Cell Lines Reveals Similarities to Prostate Carcinoma. (2005) (0)
Methylation profiles of tumour suppressor genes in Hodgkin and non-Hodgkin lymphoma cell lines (2008) (0)
3 – EBV- and HTLV-Positive Cell Lines (2001) (0)
Genomic deregulation of PRMT5 supports growth and stress tolerance in chronic lymphocytic leukemia (2020) (0)
Traumatic lumbar puncture at diagnosis of childhood acute lymphoblastic leukemia (2001) (0)
Transcriptional Deregulation of Homeobox Gene ZHX2 in Hodgkin Lymphoma (2011) (0)
Analysis of MLL Amplification and 5q Deletions in AML/MDS Cell Lines Identifies Novel Targets. (2006) (0)
LYMPHOID NEOPLASIA Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma (2016) (0)
The LL-100 panel: 100 cell lines for blood cancer studies (2019) (0)
Methylation Status of Tumor Suppressor Genes BEX2, IGSF4, RARB and TIMP3 Is Indicative for AML with Translocations of the MLL Gene. (2007) (0)
Regulation of the Expression of ICAM-1 on Pre-B Cell Lines by TNF-α and IFN-γ (1994) (0)
MHH-TALL1, a T-ALL Cell Line Expressing a Novel BCR-ABL Transcript. (2004) (0)
Extensive commentary Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma (2002) (0)
ID: 142: Th17 differentiation following SOCS1 inactivation (2015) (0)
4 – Guidelines for Characterization of Cell Lines (2001) (0)
Epigenetic Modifier Mutations in the LL-100 Panel (2018) (0)
Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis (2004) (0)
LDI-PCR in Cancer Translocation Mapping (2011) (0)
New LMO2 Translocations in T-Cell Acute Lymphoblastic Leukemia, Involving STAG2 at Xq25 and MBNL1 at 3q25: A Positive Change?. (2009) (0)
Expression of Activation-Induced Cytidine Deaminase and Transcripts of Immunoglobulin Variable Heavy Chains in Mature B-Cell Lines Lacking Immunoglobulin Protein Expression. (2004) (0)
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 (2005) (0)
K-562 (2020) (0)
A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene (2015) (0)
GM-CSF is the Mediator of the Proliferative Effect of Tumor Necrosis Factor Alpha in Acute Myeloid Leukemia-Derived Cell Lines (2003) (0)

This paper list is powered by the following services:

Hans Guenter Drexler's Academic­Influence.com Rankings

Why Is Hans Guenter Drexler Influential?

Hans Guenter Drexler's Published Works

Published Works

Hans Guenter Drexler's AcademicInfluence.com Rankings